Agile Therapeutics
AGRX
$0.40
Share price
0.00%
Change (1 day)
-93.94%
Change (1 year)
Categories
Agile Therapeutics (AGRX) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $23.3 M
According to Agile Therapeutics 's latest financial reports the company's total liabilities are $23.3 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Agile Therapeutics - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $19.78 M | -44.13% |
| 2021-12-31 | $35.41 M | 49.23% |
| 2020-12-31 | $23.73 M | 525.4% |
| 2019-12-31 | $3.79 M | 71.1% |
| 2018-12-31 | $2.21 M | -84.46% |
| 2017-12-31 | $14.27 M | -33.86% |
| 2016-12-31 | $21.57 M | 4.35% |
| 2015-12-31 | $20.67 M | 9.87% |
| 2014-12-31 | $18.82 M | -78.08% |
| 2013-12-31 | $85.84 M | -0.32% |
| 2012-12-31 | $86.12 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 423,865.67% | 🇺🇸 USA |
 Pfizer PFE | $137.21 B | 588,797.00% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 296,209.01% | 🇺🇸 USA |
 TherapeuticsMD TXMD | $22.44 M | -3.69% | 🇺🇸 USA |